and treatment of COVID-19 patients in Bojnurd Design: Shuffle block randomization Triple blinding (...) exclusion criteria: inclusion criteria Prophylactic study: Those who live with a Covid-19 patient in a single house. Have not had Covid-19 (or its symptoms) so far. Maximum 7 days have passed since start of

Study aim: Evaluation of early outcomes of liver transplantation from COVID-19 positive deceased donors and risk of transmission of COVID-19 in liver transplant Design: Non-randomized non-inferiority (...) hospital (COVID-19 center), in accordance with all health protocols, and the harvested liver will be

patients with COVID-19 2. Detection effect of Montelukast on duration of hospitalization, changes of (...) will give standard treatment of COVID-19 disease but test group will take Montelukast (Airokast, Abidi (...) exclusion criteria: Inclusion criteria: 1-All hospitalized patients with confirmed COVID-19 at both gender

from Covid-19 in improving clinical and laboratory symptoms of hospitalized patients Design: The (...) will be performed at Kosar hospital in Semnan. Convalescent plasma from COVID-19 recovered people will be injected to hospitalized patients suffering from COVID-19. Participants/Inclusion and exclusion

Study aim: Effect of Thalidomide on moderate COVID-19 pneumonia Design: Clinical trial with (...) performed in Taleghani Hospital in Tehran on patients with moderate pneumonia caused by Covid-19. Patients (...) laboratory results based on Covid-19, radiographic results indicating the presence of injury and lung

Study aim: Evaluating the efficacy of methylprednisolone mini pulse therapy on COVID-19 patients (...) which will be carried out on 60 hospitalized ‎COVID-19 patients. Settings and conduct: This clinical trial will be carried out on 60 hospitalized COVID-19 patients in Intensive care unit of imam Khomeini

Study aim: Determination of the effectiveness of Cyclotide complex in the prevention of COVID-19 virus after exposure to patients with COVID-19 and comparison with the control group Design: This (...) healthy individuals in exposure to a patient with COVID-19. Randomization will be by block randomization

of Patients with COVID-19 Design: Clinical trial with control group with parallel groups without (...) with definit diagnosis of COVID-19, Random allocation is done using a random sequence generated by the (...) patients with COVID-19 referring to the emergency departments of COVID hospitals in Najaf. No blinding will

Study aim: Reduce the infection with covid-19 and mortality of staff due to covid-19 with favipiravir treatment during the Covid- 19 epidemic. Design: Thirty people in the intensive care unit who (...) . Settings and conduct: Thirty ICU staff who are in direct contact with Covid-19 positive patients have been

in treatment of Covid-19 patients with ARDS Design: This study is a two arm parallel group, randomized clinical trial in phase 2 which will be carried out on 40 hospitalized ‎COVID-19 patients (...) on 40 hospitalized COVID-19 patients in Intensive care unit of imam Reza hospital of AJA university

Study aim: Investigate the effect of interactive digital-based psychoeducational intervention about COVID-19 on knowledge, fear, and anxiety among secondary school students Design: A quasi-experimental (...) May 2022 Main outcome variables: Covid-19 related knowledge, fear, and anxiety

COVID-19 patients and to fill the research gap for both studies that will help patients in future to (...) standardized questionnaire i.e. Interventions Evaluation on COVID-19 patients-Questionnaire. After getting the (...) COVID-19 patients-Questionnaire. All registered subjects were informed of the study protocol. Main

positive test for COVID-19 virus Design: This study is a double blind clinical trial which has two (...) nominated by a code will be gave to the patients and after 5 days the COVID-19 RtPCR will be done on the (...) . Participants/Inclusion and exclusion criteria: Every patient with positive COVID-19 PCR and positive regard for

improving pulmonary function, exercise tolerance and quality of life in Covid 19 survivors Design: Quasi (...) exclusion criteria: COVID-19 survivors (i.e., diagnosed with COVID-19, have had respiratory illness and (...) informed consent document. Hemoglobin of 9.0 gm/dl or higher COVID-19 Survivor Group documented prior COVID

with COVID-19 in Bu Ali Sina Hospital in Qazvin in 2021 Design: A double-blind randomized clinical (...) used for randomization. Settings and conduct: The study population is patients with COVID-19 admitted to Bouali sina Hospital in Qazvin in 2021 who has developed COVID-19 pneumonia and pulmonary

Study aim: Evaluation the efficacy and safety of Hydroxychloroquine administration for COVID-19 (...) over 18 years old and had a close contact with a COVID-19 case at least in past 4 days and signed the informed consent form included. Also, pervious cases of COVID-19 and who had flu like symptoms or those

which will be carried out on 40 hospitalized ‎COVID-19 patients. Patients randomly divided into two groups. Settings and conduct: This clinical trial will be carried out on 40 hospitalized COVID-19 (...) criteria: Inclusion Criteria: Patients admitted to ICU with moderate to severe Covid-19 infection needs

with COVID-19 Design: The randomized clinical trial, parallel groups, 200 patients will be enrolled (...) will be prescribed standard regimen for COVID-19. Patients in Metformin group will be prescribed Metformin 500 mg BID for two weeks and standard regimen for COVID-19. The routine lab data, hospitalization

Study aim: The effect of cognitive-behavioral intervention in reducing fear of COVID-19 symptoms (...) disorder due to the COVID-19 Design: This study is a randomized controlled trial with a parallel and double-blind design, conducted on 60 patients who have tested positive for COVID-19 and have been

Study aim: Evaluation of the effectiveness of intravenous infusion of human COVID-19 hyperimmune plasma with specific antibody titer in hospitalized patients with Covid-19: a randomized clinical trial (...) COVID-19 pneumonia based on PCR or pulmonary imaging; Presenting clinical symptoms of COVID-19 (fever

patients with respiratory failure caused by the COVID-19 Design: Clinical trial with one intervention group, with no control group and no blindness on 40 hospitalized patients with severe forms of COVID-19 (...) patients with severe forms of COVID-19. Inclusion Criteria: Patients with diagnosis of COVID-19 based on

COVID-19 Design: Clinical trial with controlled group, parallel design, double-blinded, multi-centric (...) informed consent; Age of 18 years or more; Exposure and close contact with a COVID-19 patients within 4 (...) for prophylaxis or treatment if COVID-19; patients with any sign and symptoms of COVID-19; Taking the

Lopinavir-ritonavir in COVID-19 patients Design: Clinical trial with parallel randomized groups Settings (...) study, patients who were between 18 and 100 years old, confirmed COVID-19 with RT-PCR, and signed the (...) liver disease, mild cases of COVID-19 (outpatients) or critical cases of COVID-19 (needs to ICU or

patients with COVID-19 Design: The randomized clinical trial with a parallel group design in which 200 (...) standard regimen for COVID-19. Patients in Metformin group will be prescribed Metformin 500 mg BID for two weeks and standard regimen for COVID-19. The routine lab data, need for hospitalization and mortality

Study aim: Evaluation of safety and efficacy of FLUVAR® in prevention of COVID-19 compared to (...) volunteers at risk of COVID-19 Blinding: The researcher is unaware of which drug or placebo is being (...) - Participating in another clinical trial for COVID-19 Intervention groups: FLUVAR® nasal spray group 500µl once